首页/数据集/Dataset from A Study to Evaluate GSK Biologicals' Candidate Formulations of Pneumococcal Vaccines (GSK2189241A) in Elderly Subjects.

Dataset from A Study to Evaluate GSK Biologicals' Candidate Formulations of Pneumococcal Vaccines (GSK2189241A) in Elderly Subjects.

NIAID Data Ecosystem2026-05-02 收录

肺炎球菌疫苗

老年人群免疫原性评估

数据链接：

https://doi.org/10.25934/00000689 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this observer-blind study is to evaluate the safety, reactogenicity and immunogenicity of pneumococcal vaccines in elderly. Subjects will be vaccinated twice with an interval of two months.

应用场景：

创建时间：

2024-11-27

疫苗市场分析

肺炎球菌疫苗

Global 13-Valent Pneumococcal Conjugate Vaccine Market Report 2022 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present a

IMR REPORTS60

The distribution of PCV aliquot given to children enrolled into the study, Ethiopia, 2011/2012.

儿童疫苗接种分布

肺炎球菌疫苗

The distribution of PCV aliquot given to children enrolled into the study, Ethiopia, 2011/2012.

NIAID Data Ecosystem50

Pneumococcal Vaccine Market Size, Share, Growth Analysis Report By Sector (Public and Private), By Vaccine Type (Pneumococcal Polysaccharide Vaccine and Pneumococcal Conjugate Vaccine), By Distribution Channel (Non-Government Organizations, Distribution Partner Companies, and Government Authorities), By Product Type (Pneumovax 23, Synflorix, and Prevnar 13), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030

肺炎球菌疫苗

市场分析

The global pneumococcal vaccination market was assessed at USD 8.57 billion in 2021 and is expected to exceed USD 12 billion by 2030 at a CAGR of 5.34%.

www.fnfresearch.com2024-11-29 更新20

Intranasal Immunization with Pneumococcal Polysaccharide Conjugate Vaccines Protects Mice against Invasive Pneumococcal Infections

肺炎球菌疫苗

黏膜免疫机制

Host defenses against Streptococcus pneumoniae depend largely on opsonophagocytosis mediated by antibodies and complement. Since pneumococcus is a respiratory pathogen, mucosal immune responses may pl

PubMed Central50

Preventable fraction of all-cause pneumonia hospitalisations in undervaccinated children under 5 years at deciles of PCV coverage, New South Wales and Western Australia, 2001–2012.

肺炎球菌疫苗

公共卫生政策

Preventable fraction of all-cause pneumonia hospitalisations in undervaccinated children under 5 years at deciles of PCV coverage, New South Wales and Western Australia, 2001–2012.

Figshare2021-08-03 更新20

Dataset from A Study to Evaluate GSK Biologicals' Candidate Formulations of Pneumococcal Vaccines (GSK2189241A) in Elderly Subjects.

资源简介：

相关数据集